Utilizing a passionate and talented team, VoxCell has developed an extraordinary dual purpose 3D Bioprinter/Printer. Our unique 3D Bioprinter uses a state of the art laser with a process that crosslinks liquid polymers and bioinks with extreme precision, producing highly detailed 3D printed parts. This unique process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional 3D printers.
Our printer will produce highly detailed nanoscale tissue models with vasculature, mimicking human tissue, for in vitro drug testing and is aimed to dramatically reduce the time and resources spent in pre-clinical trials, which typically run approximately three years and $122M USD on average, and increase the successful translation between pre-clinical trial data and clinical trial results - currently less than 8%! The sooner drugs can be tested in truly biomimetic tissues, the better the development of the drug can be.
Our mission is simple: we want to change the world. We want to disrupt the drug development industry by getting life changing therapies into the market and the hands of people who need it most; faster and at a lower cost.